Eli Mintz News Today

Compugen (NASDAQ:CGEN – Get Rating) and ProKidney (NASDAQ:PROK – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Analyst Recommendations This is a breakdown of current ratings and recommmendations […]

StockNews.com assumed coverage on shares of Compugen (NASDAQ:CGEN – Get Rating) in a research note published on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the company. Jefferies Financial Group cut Compugen from a hold rating to an underperform […]

StockNews.com started coverage on shares of Compugen (NASDAQ:CGEN – Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities research analysts have also recently weighed in on the stock. SVB Leerink reiterated an outperform rating on shares of Compugen in a research report […]

Investment analysts at StockNews.com initiated coverage on shares of Compugen (NASDAQ:CGEN – Get Rating) in a note issued to investors on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. Several other research analysts have also commented on CGEN. SVB Leerink restated an “outperform” rating on shares of Compugen in a research […]

StockNews.com began coverage on shares of Compugen (NASDAQ:CGEN – Get Rating) in a research report sent to investors on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities analysts also recently issued reports on the stock. SVB Leerink restated an outperform rating on shares of Compugen in a research […]

Compugen (NASDAQ:CGEN – Get Rating) announced its quarterly earnings results on Monday. The biotechnology company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.01, MarketWatch Earnings reports. During the same period last year, the company earned ($0.11) EPS. Compugen Trading Up 10.0 % Shares of Compugen stock opened […]

Stockman Wealth Management Inc. acquired a new stake in Compugen Ltd. (NASDAQ:CGEN – Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 70,800 shares of the biotechnology company’s stock, valued at approximately $51,000. Stockman Wealth Management Inc. owned 0.08% of Compugen […]

Compugen Ltd. (NASDAQ:CGEN – Get Rating) saw a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 1,890,000 shares, a decline of 5.5% from the March 15th total of 2,000,000 shares. Based on an average daily trading volume, of 429,600 shares, the days-to-cover ratio is […]

Graphite Bio (NASDAQ:GRPH – Get Rating) and Compugen (NASDAQ:CGEN – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Volatility and Risk Graphite Bio has a beta of 0.01, […]

Antonetti Capital Management LLC raised its stake in shares of Compugen Ltd. (NASDAQ:CGEN – Get Rating) by 12.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 583,277 shares of the biotechnology company’s stock after buying an additional […]